Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Businessweek Archives

Fallen Angels To Resurrect

Inside Wall Street


Notwithstanding the market's climb to record highs, investment manager Tony Spare finds that bargains still abound. Several of his picks are "fallen angels"--former growth stocks that disappointed the Street and that have hardly budged in the bull market. He has been snapping up shares of Bristol-Myers Squibb (BMY), Tambrands (TMB), and Dun & Bradstreet (RND).

Spare considers Bristol-Myers, currently trading at 66, to be way undervalued. Seen by analysts mainly as a drug company, Bristol-Myers is also a "diversified international consumer-products company that's well-positioned for strong growth worldwide," insists Spare. Its balance sheet remains strong, he adds, and recent earnings disappointments "have masked its excellent cash flow and leading market-share position of its many products." He sees the stock hitting 75 in a year.

The Tambrands line of feminine-protection products, says Spare, "ranks very high in market share worldwide." He feels encouraged by a strong balance sheet and by a record of 47 years of steadily increasing dividends. He thinks the stock, now trading at 43, is also cheap--and will rise to 55 during this year.

Dun & Bradstreet has made its name, notes Spare, on the strength of publishing and financial-database operations worldwide. The stock is buttressed, he says, by a strong cash flow and high dividend yield--of 5%. His target for the stock, now priced at 52, for the year is 60.BY GENE G. MARCIAL

blog comments powered by Disqus